Stephen C. Turner
Algemeen Directeur bij Cytorecovery, Inc.
Profiel
Stephen C.
Turner is the founder of PBI, Inc. (2001), Protea Biosciences, Inc. (2002), Bethesda Research Laboratories, Inc. (1975), and Protea Biosciences Group, Inc. (2001).
At PBI, Inc., he held no titles.
At Protea Biosciences, Inc., he was the Chairman & Chief Executive Officer (inactive).
At Bethesda Research Laboratories, Inc., he was the Chairman & Chief Executive Officer (inactive).
At Protea Biosciences Group, Inc., he was the Chairman & Chief Executive Officer (inactive).
Mr. Turner's current job is as the Chief Executive Officer at CytoRecovery, Inc. Mr. Turner's former jobs include being the President & Chief Executive Officer at Oncor, Inc. (1984-1997), Marketing Director at Becton, Dickinson & Co., President & Chief Executive Officer at Quorum Sciences, Inc. (1999-2001), and Chairman, President & Chief Executive Officer at SRKP 5, Inc. (2011-2012).
Mr. Turner's education history includes an undergraduate degree from Stanford University (1967).
Actieve functies van Stephen C. Turner
| Bedrijven | Functie | Begin |
|---|---|---|
Cytorecovery, Inc.
 Cytorecovery, Inc. Miscellaneous Commercial ServicesCommercial Services Cytorecovery, Inc. develops microfluidic technology intended to recover biological cells from samples. The company is headquartered in Blacksburg, VA. | Algemeen Directeur | - |
Eerdere bekende functies van Stephen C. Turner
| Bedrijven | Functie | Einde |
|---|---|---|
| PROTEA BIOSCIENCES GROUP, INC | Algemeen Directeur | 26-10-2017 |
SRKP 5, Inc.
 SRKP 5, Inc. Miscellaneous Commercial ServicesCommercial Services SRKP 5, Inc. was incorporated in the State of Delaware on May 24, 2005. Since inception, the company has been engaged in organizational efforts and obtaining initial financing. The firm was formed as a vehicle to pursue a business combination through the acquisition of, or merger with, an operating business. The firm, based on proposed business activities, is a 'blank check' company. It was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly held corporation. The company will not restrict its potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business. | Voorzitter | 12-04-2012 |
Quorum Sciences, Inc.
 Quorum Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Aurora Biosciences Corp., Quorum Sciences, Inc. develops quorum sensing and biofilms in microorganisms. The company is based in Frederick, MD. Quorum Sciences was acquired by Aurora Biosciences Corp. on October 04, 2000 for $3.82 million. | President | 01-01-2001 |
Oncor, Inc.
 Oncor, Inc. Medical SpecialtiesHealth Technology Oncor, Inc. markets a variety of molecular biology products, including restriction enzymes and markets related apparatus and equipment. The company was founded in July 1983 and is headquartered in Gaithersburg, MD. | President | 01-01-1997 |
| Bethesda Research Laboratories, Inc. | Oprichter | 01-01-1983 |
Opleiding van Stephen C. Turner
| Stanford University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Oncor, Inc.
Oncor, Inc. Medical SpecialtiesHealth Technology Oncor, Inc. markets a variety of molecular biology products, including restriction enzymes and markets related apparatus and equipment. The company was founded in July 1983 and is headquartered in Gaithersburg, MD. | Health Technology |
SRKP 5, Inc.
SRKP 5, Inc. Miscellaneous Commercial ServicesCommercial Services SRKP 5, Inc. was incorporated in the State of Delaware on May 24, 2005. Since inception, the company has been engaged in organizational efforts and obtaining initial financing. The firm was formed as a vehicle to pursue a business combination through the acquisition of, or merger with, an operating business. The firm, based on proposed business activities, is a 'blank check' company. It was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly held corporation. The company will not restrict its potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business. | Commercial Services |
Protea Biosciences, Inc.
 Protea Biosciences, Inc. Medical SpecialtiesHealth Technology Protea Biosciences, Inc. develops technology for micro fluidic protein separation and detection. The firm develops new technology for the identification, characterization, and quantization of biologically-important molecules for basic research, pharmaceutical development, and diagnostic applications. the company was founded by Steve Turner in 2001 and is headquartered in Morgantown, WV. | Health Technology |
Quorum Sciences, Inc.
Quorum Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Aurora Biosciences Corp., Quorum Sciences, Inc. develops quorum sensing and biofilms in microorganisms. The company is based in Frederick, MD. Quorum Sciences was acquired by Aurora Biosciences Corp. on October 04, 2000 for $3.82 million. | Health Technology |
PBI, Inc.
 PBI, Inc. Specialty StoresRetail Trade PBI, Inc. operates as a furniture store. The private company is based in Annapolis, MD. The company was founded by Stephen C. Turner. | Retail Trade |
| Bethesda Research Laboratories, Inc. | |
Protea Biosciences Group, Inc.
 Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Protea Biosciences Group, Inc. engaged in the provision of molecular information services. It offers direct analysis, mapping, and display of biologically active molecules in living cells and tissue samples through its platform technology. The company was founded by Stephen C. Turner in July 2001 and was headquartered in Morgantown, WV. | Commercial Services |
Cytorecovery, Inc.
Cytorecovery, Inc. Miscellaneous Commercial ServicesCommercial Services Cytorecovery, Inc. develops microfluidic technology intended to recover biological cells from samples. The company is headquartered in Blacksburg, VA. | Commercial Services |
